Patents by Inventor Ismael Silva

Ismael Silva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
    Publication number: 20220034892
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 3, 2022
    Applicant: Metabolomycs, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
    Publication number: 20220034893
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Application
    Filed: October 19, 2021
    Publication date: February 3, 2022
    Applicant: Metabolomycs, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
    Patent number: 11181524
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Grant
    Filed: June 14, 2019
    Date of Patent: November 23, 2021
    Assignee: Metabolomycs, Inc
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • Metabolomic signatures for predicting, diagnosing, and prognosing various diseases including cancer
    Patent number: 11181525
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: November 23, 2021
    Assignee: Metabolomyes, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
    Publication number: 20210003578
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Application
    Filed: March 8, 2020
    Publication date: January 7, 2021
    Applicant: Metabolomycs, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • METABOLIC SIGNATURES ASSOCIATED WITH DIAGNOSIS, DISEASE PROGRESSION, AND IMMUNOLOGICAL RESPONSE TO TREATMENT OF PATIENTS WITH COVID-19
    Publication number: 20200386766
    Abstract: A system and method for using new biomarkers to assess individual diseases, including, but not limited to, a patient's prognosis before and/or after being diagnosed with the disease. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and/or treat various diseases, including, but not limited to, COVID-19.
    Type: Application
    Filed: July 6, 2020
    Publication date: December 10, 2020
    Applicant: Metabolomycs, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
    Publication number: 20200200754
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Application
    Filed: December 16, 2019
    Publication date: June 25, 2020
    Applicant: Metabolomycs, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora
  • Metabolomic Signatures for Predicting, Diagnosing, and Prognosing Various Diseases Including Cancer
    Publication number: 20190383819
    Abstract: A system and method for using new biomarkers to assess individual diseases is provided. In one embodiment of the present invention, absolute quantification of annotated metabolites by mass spectrometry is used to identify certain biomarkers and derivatives thereof (i.e., signatures), which are then used to screen for, diagnose, predict, prognose, and treat various diseases, including, but not limited to, breast cancer, ovarian cancer, colorectal cancer, pancreatic cancer, and acute graft-versus-host disease.
    Type: Application
    Filed: June 14, 2019
    Publication date: December 19, 2019
    Applicant: Metabolomycs, Inc.
    Inventors: Robert Nagourney, Ismael Silva, Paulo D'Amora